Rani Therapeutics Holdings, Inc. announced on January 2, 2022, upon the recommendation of its Nominating and Corporate Governance Committee, the board of directors (the “Board”) of company elected Lisa Rometty as a director of the Company, effective January 3, 2022, with a term expiring at the Company's next annual meeting of stockholders.